Masks are required at all of our facilities | Visitor Restrictions | COVID-19 Vaccine and Boosters

Menu
Close Search Opener

SWOG 1900A:A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)

December 10, 2018
pending
Cancer - Lung
Principal Investigator: Ding Wang, MD
CANCER, LUNG, LUNG CANCER, STAGE 4, NON SMALL CELL, NSCLC
Open